20 AIDX SEC Filings

NASDAQ AIDX
$0.53 -0.04 (-6.20%)
As of: Sep 10, 2026 · 2:28 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document 20/20 Biolabs, Inc. (AIDX) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index